Cerus Corporation (CERS)vsMedtronic PLC (MDT)
CERS
Cerus Corporation
$1.77
-2.75%
HEALTHCARE · Cap: $330.54M
MDT
Medtronic PLC
$87.89
+1.51%
HEALTHCARE · Cap: $110.62B
Smart Verdict
WallStSmart Research — data-driven comparison
Medtronic PLC generates 17114% more annual revenue ($35.48B vs $206.13M). MDT leads profitability with a 13.0% profit margin vs -7.6%. MDT earns a higher WallStSmart Score of 56/100 (C).
CERS
Avoid32
out of 100
Grade: F
MDT
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CERS.
Margin of Safety
-255.7%
Fair Value
$24.34
Current Price
$87.89
$63.55 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 20.0%
Generating 2.3B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Elevated debt levels
ROE of -25.7% — below average capital efficiency
Earnings declined 11.8%
Comparative Analysis Report
WallStSmart ResearchBull Case : CERS
Revenue growth of 13.7% demonstrates continued momentum.
Bull Case : MDT
The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.
Bear Case : CERS
The primary concerns for CERS are EPS Growth, Market Cap, Debt/Equity. Debt-to-equity of 1.60 is elevated, increasing financial risk.
Bear Case : MDT
The primary concerns for MDT are EPS Growth.
Key Dynamics to Monitor
CERS profiles as a turnaround stock while MDT is a value play — different risk/reward profiles.
CERS carries more volatility with a beta of 1.53 — expect wider price swings.
CERS is growing revenue faster at 13.7% — sustainability is the question.
MDT generates stronger free cash flow (2.3B), providing more financial flexibility.
Bottom Line
MDT scores higher overall (56/100 vs 32/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cerus Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California.
Visit Website →Medtronic PLC
HEALTHCARE · MEDICAL DEVICES · USA
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?